ClinicalTrials.Veeva

Menu

Safety and Efficacy of a Hypoglossal Nerve Implant for the Treatment of Obstructive Sleep Apnea (OSA)

I

ImThera Medical

Status

Completed

Conditions

Syndrome, Obstructive Sleep Apnea
Sleep Apnea Syndromes
Respiration Disorders
Sleep Apnea, Obstructive
Signs and Symptoms, Respiratory

Treatments

Device: aura6000 System

Study type

Interventional

Funder types

Industry

Identifiers

NCT01532180
IMT 2009-01/02/03

Details and patient eligibility

About

The objective of the study is to determine the safety and preliminary efficacy in patients utilizing the aura6000 System for the treatment of Obstructive Sleep Apnea (OSA).

Enrollment

14 patients

Sex

All

Ages

25 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Moderate to severe obstructive sleep apnea (AHI 15 to 60).
  • Cannot or will not tolerate CPAP treatment.
  • Body mass index (BMI) between 25 and 40
  • Able to read, understand, sign and date the written informed consent form

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

14 participants in 1 patient group

THN Therapy
Experimental group
Treatment:
Device: aura6000 System

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems